Clinical TrialID 8206

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

NCT05913427

Adrenocortical Carcinoma

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8206
Evidence Id
8206
Core Evidence Id
8206
Source Clinical Trial Id
8204
Herb2 Clinical Trial Id
HBCT008204
Nct Id
NCT05913427
Title
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
Status
Recruiting
Phase
Phase 2
Study Result
No
Study Condition
Adrenocortical Carcinoma
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG|DRUG: Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
80
Outcome Measure
Evaluation of the activity of the combination regimen (EDP-M plus progesterone (EDP-MP) versus EDP-M plus placebo) in advanced/ metastatic patients with ACC., Comparison of proportion of patients attaining an Objective Response (Objective Response Rate, ORR), evaluated by RECIST criteria between the 2 treatment arms., 18 months
Sponsor Collaborator
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Funded By
OTHER
Location
Alfredo Berruti, Brescia, 25123, Italy
Other Id
ASSTBS-FARONCO- PESETA-20
Start Date
2022-06-08
Primary Completion Date
2027-06-08
Completion Date
2027-06-08
First Posted
2023-06-22
Results First Posted
Last Update Posted
2024-08-01
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05913427
Title Cn
Title En
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
Bilingual Status
semi_complete